The Safety and Effects of the Beta-Blocker, Nadolol, in Mild Asthma; An Open-label Pilot Study

Beta-blockers are currently contraindicated in asthma because their acute administration may be associated with worsening bronchospasm. However, their effects and safety with their chronic administration are not well evaluated. The rationale for this pilot study was based on the paradigm shift that...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hanania, Nicola A, Singh, Supria, Eli-Wali, Rami, Flashner, Michael, Franklin, Amie E, Garner, William J, Dickey, Burton F, Parra, Sergio, Ruoss, Stephen J, Shardonofsky, Felix, O'Connor, Brian J, Page, Clive, Bond, Richard A
Formato: Artigo
Lenguaje:Inglês
Publicado: 2007
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2254137/
https://ncbi.nlm.nih.gov/pubmed/17703976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pupt.2007.07.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares